BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17982649)

  • 1. Dependency of repair of radiation-induced damage on p53 status and efficient inhibition of the repair with wortmannin treatment in vivo, with reference to the effect on intratumor quiescent cell population.
    Masunaga S; Takahashi A; Ohnishi K; Nagata K; Suzuki M; Kashino G; Kinashi Y; Ohnishi T; Ono K
    Oncol Rep; 2007 Dec; 18(6):1589-96. PubMed ID: 17982649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells.
    Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
    Radiat Med; 2003; 21(3):120-7. PubMed ID: 12868860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations.
    Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Nagata K; Suzuki M; Kinashi Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):570-7. PubMed ID: 15380594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
    Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of
    Masunaga SI; Tano K; Sanada Y; Suzuki M; Takahashi A; Ohnishi K; Ono K
    World J Oncol; 2019 Jun; 10(3):132-141. PubMed ID: 31312280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
    Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams.
    Masunaga SI; Uzawa A; Hirayama R; Matsumoto Y; Sakurai Y; Tanaka H; Tano K; Sanada Y; Suzuki M; Maruhashi A; Ono K
    World J Oncol; 2015 Aug; 6(4):398-409. PubMed ID: 28983338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
    Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
    Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Ono K
    Acta Oncol; 2008; 47(6):1087-93. PubMed ID: 18607878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams.
    Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Sakurai Y; Nagata K; Suzuki M; Kashino G; Kinashi Y; Tanaka H; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):221-8. PubMed ID: 18086390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of repair of radiation-induced damage by mild temperature hyperthermia, referring to the effect on quiescent cell populations.
    Masunaga S; Nagata K; Suzuki M; Kashino G; Kinashi Y; Ono K
    Radiat Med; 2007 Oct; 25(8):417-25. PubMed ID: 17952547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of
    Masunaga SI; Kobayashi J; Tano K; Sanada Y; Suzuki M; Ono K
    J Clin Med Res; 2018 Nov; 10(11):815-821. PubMed ID: 30344816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells.
    Masunaga S; Ono K; Takahashi A; Ohnishi T; Kinashi Y; Takagaki M
    Eur J Cancer; 2002 Mar; 38(5):718-27. PubMed ID: 11916556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.
    Masunaga S; Ono K; Takahashi A; Sakurai Y; Ohnishi K; Kobayashi T; Kinashi Y; Takagaki M; Ohnishi T
    Jpn J Cancer Res; 2002 Dec; 93(12):1366-77. PubMed ID: 12495477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
    Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-dependent thermal enhancement of cellular sensitivity in human squamous cell carcinomas in relation to LET.
    Takahashi A; Ohnishi K; Ota I; Asakawa I; Tamamoto T; Furusawa Y; Matsumoto H; Ohnishi T
    Int J Radiat Biol; 2001 Oct; 77(10):1043-51. PubMed ID: 11682009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.